Plasmodium Falciparum: Clinical Trials

6 trials for Plasmodium Falciparum, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6
Phase 12Completed 2
Phase 31Completed 1

Follow Plasmodium Falciparum: new trials by email Literature Review of Plasmodium Falciparum trials Research Report on Plasmodium Falciparum

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy
Malaria Vaccine RTS,S/AS01E, Abhayrab rabies vaccine, Dihydroartemisinin-piperaquine (DHA/Pip) - Plasmodium Falciparum
Phase 2CompletedPATH6202020-11-062024-07-19
Safety and Protective Efficacy of Pb(PfCS@UIS4)
Pb(PfCS@UIS4)-infected mosquitoes, Challenge infection P. falciparum - Malaria,Falciparum, Plasmodium Falciparum
Phase 1 / Phase 2CompletedRadboud University Medical Center242017-05-292022-03-04
Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection
BCG vaccination - Malaria, Plasmodium Falciparum
Phase 2CompletedRadboud University Medical Center202016-04-012017-04-20
Low Dose Primaquine for Clearance of Gametocytes
Artemether-lumefantrine combination, Artemether-Lumefantrine with a single dose of 0.25mg/kg primaquine, Artemether-Lumefantrine with a single dose of 0.4mg/kg primaquine - Malaria, Asymptomatic Malaria
Phase 2 / Phase 3CompletedLondon School of Hygiene and Tropical Medicine3602013-09-012015-09-02
NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1
NMRC-M3V-Ad-PfCA, NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA - Plasmodium Falciparum
Phase 1 / Phase 2CompletedU.S. Army Medical Research and Development Command592006-10-122021-05-21
Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults.
RTS, S/AS01B, RTS, S/AS02A, Rabipur (Rabies) Vaccine - Plasmodium Falciparum
Phase 2CompletedU.S. Army Medical Research and Development Command2552005-07-012021-02-12

Narrower conditions

Malaria, Falciparum (6)  ·  Malaria (2)  ·  Adenoviridae Infections (1)

Broader conditions

Infections (6)  ·  Mosquito-Borne Diseases (6)  ·  Parasitic Diseases (6)  ·  Protozoan Infections (6)  ·  Vector Borne Diseases (6)  ·  Malaria (4)  ·  DNA Virus Infections (1)  ·  Virus Diseases (1)

Interventions

Artemether, Lumefantrine Drug Combination (2)  ·  Primaquine (2)  ·  RTS malaria vaccine (1)  ·  RTS,S-AS01B vaccine (1)  ·  RTS,S-AS02A vaccine (1)  ·  Vaccines (1)

Sponsors

Radboud University Medical Center (2)  ·  U.S. Army Medical Research and Development Command (2)  ·  London School of Hygiene and Tropical Medicine (1)  ·  PATH (1)

Countries

Kenya (2)  ·  Netherlands (2)  ·  Burkina Faso (1)  ·  United States (1)

Top investigators

Alfred Tiono, PhD, MD (1)  ·  Cindy Tamminga, MD, MPH (1)  ·  Jona Walk, MD (1)  ·  Lucas O Tina, MD, MTM&H (1)  ·  Mihai Netea, Prof. (1)  ·  Robert Sauerwein, MD PhD (1)  ·  Robert Sauerwein, Prof. (1)

Results publications

PMID 19649245, PMID 22003383, PMID 22003411, PMID 23899517, PMID 25211344, PMID 26292027, PMID 26292257, PMID 26952094, PMID 27695088, PMID 28289025, PMID 32434846, PMID 40439411

NIH funding

2015 (1)